| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |